Skip to main content
Haemato AG logo

Haemato AG — Investor Relations & Filings

Ticker · HAEK ISIN · DE000A289VV1 LEI · 529900Q3CGRYVCW7E340 F Wholesale and retail trade
Open in API
Filings indexed 188 across all filing types
Latest filing 2014-04-14 Earnings Release
Country DE Germany
Listing F HAEK

About Haemato AG

https://haemato.de/en/start.html

Haemato AG is a pharmaceutical company focused on the specialty pharma market, concentrating on treatments for chronic diseases and high-priced therapies. The company's business activities include the development, acquisition, licensing, and distribution of a product portfolio that comprises innovative patent-protected medicines, biosimilars, and generics. The portfolio also extends to narcotics, including cannabis products, as well as over-the-counter (OTC) products and special cosmetics. Haemato AG's primary therapeutic areas of focus are HIV/AIDS, neurology, oncology, rheumatology, and ophthalmology.

Recent filings

Filing Released Lang Actions
HAEMATO AG: 2013: Final IFRS results, sales of EUR 173.57 million, annual net income of EUR 8.38 million; proposal on the increase in the dividend from EUR 0.25 to EUR 0.30 per share
Earnings Release Classification · 100% confidence The document is a short corporate news release dated April 14, 2014, announcing the final IFRS results for the year 2013 (sales of EUR 173.57 million, net income of EUR 8.38 million) and explicitly proposing an increase in the dividend to EUR 0.30 per share for approval at the upcoming Annual General Meeting (AGM). Since it contains key financial highlights (sales, profit) and an immediate dividend proposal, it strongly aligns with an Earnings Release (ER). Although it mentions the AGM, the primary focus is the financial performance summary, not the AGM materials themselves or the formal dividend notice (DIV). Given the structure and content (final results summary), ER is the most appropriate classification, rather than RPA, as it delivers the results directly, not just an announcement of a forthcoming report. FY 2013
2014-04-14 English
HAEMATO AG: 2013: Endgultiges IFRS-Ergebnis, Umsatz 173,57 Mio. Euro, Jahresuberschuss 8,38 Mio. Euro; Vorschlag Erhohung der Dividende von 25 Cent auf 30 Cent je Aktie
Earnings Release Classification · 95% confidence The document is a short news release dated April 14, 2014, detailing the final IFRS results for the year 2013 (Revenue: 173.57 Mio. Euro, Net Income: 8.38 Mio. Euro). Crucially, it also announces a proposal to increase the dividend from 25 cents to 30 cents per share, to be voted on at the AGM on May 28, 2014. This content combines key financial highlights (typical of an Earnings Release) with a specific dividend proposal announcement. Since it provides the key financial outcomes for the period and explicitly mentions the dividend proposal, it aligns best with the 'Earnings Release' (ER) category, which covers initial announcements of periodical financial results (key highlights only). While it mentions the dividend (DIV), the primary focus is the full-year financial summary. FY 2013
2014-04-14 German
Datum:24.02.2014
Annual Report Classification · 100% confidence The document is a German 'Jahresabschluss' (Annual Financial Statement) for Windsor AG for the fiscal year 2012. It contains a balance sheet (Bilanz) with detailed assets and liabilities, as well as an appendix (Anhang) detailing accounting and valuation methods. This constitutes a comprehensive annual financial report. In the context of the provided filing categories, this is classified as an Annual Report (10-K). FY 2012
2014-02-24 German
HAEMATO AG: 2013: Preliminary IFRS results, sales of EUR 174.6 million, annual net income of EUR 8.2 million; confirmation of dividend policy
Earnings Release Classification · 100% confidence The document is a short news release dated February 21, 2014, titled 'HAEMATO AG: 2013: Preliminary IFRS results, sales of EUR 174.6 million, annual net income of EUR 8.2 million; confirmation of dividend policy'. It provides key preliminary financial figures (sales, net income) for the full year 2013 and mentions confirmation of the dividend policy. This content aligns perfectly with an Earnings Release (ER), which is the initial announcement of periodical financial results, typically highlighting key figures before the full report is issued. It is too brief and summary-focused to be a full Annual Report (10-K) or Interim Report (IR). The final lines indicate dissemination via DGAP, which often carries ERs. FY 2013
2014-02-21 English
Korrektur der Veroffentlichung vom 21.02.2014, 10:28 Uhr MEZ - HAEMATO AG: 2013: Vorlaufiges IFRS-Ergebnis, Umsatz 174,6 Mio. Euro, Jahresuberschuss 8,2 Mio. Euro; Bestatigung Dividendenpolitik
Earnings Release Classification · 100% confidence The document is a short corporate news release dated February 21, 2014, announcing preliminary IFRS results for the year 2013, including revenue (€174.6M) and net profit (€8.2M), and confirming the dividend policy. This content structure—key financial highlights for a period (annual in this case) released before the full official report—is characteristic of an Earnings Release (ER). Although it covers the full year, it explicitly states 'Vorläufiges IFRS-Ergebnis' (Preliminary IFRS Result) and focuses on headline figures rather than the comprehensive detail expected in a 10-K or a full Interim Report (IR). Given the focus on preliminary results, ER is the most appropriate classification. FY 2013
2014-02-21 German
HAEMATO AG: 2013: Vorlaufiges IFRS-Ergebnis, Umsatz 174,6 Mio. Euro, Jahresuberschuss 8,2 Mio. Euro; Bestatigung Dividendenpolitik
Earnings Release Classification · 100% confidence The document is a short news release dated February 21, 2014, titled 'HAEMATO AG: 2013: Vorläufiges IFRS-Ergebnis, Umsatz 174,6 Mio. Euro, Jahresüberschuss 8,2 Mio. Euro; Bestätigung Dividendenpolitik'. It explicitly states preliminary (vorläufiges) IFRS results for the full year 2013, including revenue and net income figures, and confirms the dividend policy. This content structure—announcing key financial highlights for a period without providing the full, detailed report—is characteristic of an Earnings Release (ER). It is too brief and focused on highlights to be a full Annual Report (10-K) or Interim Report (IR). The final line indicates it was distributed via DGAP, which often carries ERs. FY 2013
2014-02-21 German

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.